Cushing syndrome in the McCune-Albright syndrome.
BACKGROUND
Cushing syndrome (CS) is a rare but potentially fatal feature of McCune-Albright syndrome (MAS). Optimal management, prognostic features, and long-term follow-up of this disorder have not been described.


METHODS
The study was conducted at an academic tertiary care center.


METHODS
A total of 112 patients participating in a natural history study at the National Institutes of Health (NIH) were evaluated, and 21 published cases were reviewed.


METHODS
Subjects received observation, medical management, or bilateral adrenalectomy.


METHODS
We measured prevalence, prognostic factors, and natural history.


RESULTS
The prevalence of CS among NIH patients was 7.1%. The median age at diagnosis was 3 months. Clinical features included "Cushingoid facies" (66.7%), failure to thrive (60.0%), low birth weight (50.0%), liver disease (36.7%), and heart disease (26.7%). Six patients (20.0%) died, four after adrenalectomy. Death was more likely in patients with comorbid heart disease (odds ratio, 13.3; P < 0.05). Of 23 survivors, 13 underwent adrenalectomy, and 10 exhibited spontaneous resolution. Two patients with spontaneous resolution who were tested later in life (3 and 15 yr after resolution) continued to have low-level, autonomous adrenal function with biochemical adrenal insufficiency. Compared to MAS patients without CS, patients with CS were more likely to have a cognitive/developmental disorder (44.4 vs. 4.8%; P < 0.001; odds ratio, 8.8).


CONCLUSIONS
Comorbid heart and liver disease were poor prognostic markers and may indicate the need for prompt adrenalectomy. The high incidence of cognitive disorders indicates a need for close developmental follow-up and parental counseling. Patients with spontaneous resolution of CS may develop adrenal insufficiency, and they require long-term monitoring.
Brown
Rebecca J
RJ
Clinical Endocrinology Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland 20892-4320, USA.
Kelly
Marilyn H
MH
Collins
Michael T
MT
D000311:Adrenal Glands / Q000503:physiopathology; D000315:Adrenalectomy; D017668:Age of Onset; D016022:Case-Control Studies; D003480:Cushing Syndrome / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D018450:Disease Progression; D005260:Female; D005359:Fibrous Dysplasia, Polyostotic / Q000150:complications* / Q000175:diagnosis / Q000628:therapy; D006331:Heart Diseases / Q000209:etiology; D006801:Humans; D006854:Hydrocortisone / Q000097:blood / Q000652:urine; D007223:Infant; D007231:Infant, Newborn; D007236:Infant, Small for Gestational Age; D008107:Liver Diseases / Q000209:etiology; D008297:Male; D011379:Prognosis
D006854:Hydrocortisone